These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26365276)

  • 1. Feasibility of an Alternative Option for the Management of Male Lower Urinary Tract Symptoms.
    Roehrborn CG; Lowe FC; Gittelman M; Wruck JM; Verbeek AE
    J Urol; 2016 Jan; 195(1):125-30. PubMed ID: 26365276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Dipstick Urinalysis Screening Beneficial in Men with Lower Urinary Tract Symptoms?
    Lowe FC; Michel MC; Wruck JM; Verbeek AE
    Adv Ther; 2019 Oct; 36(10):2954-2967. PubMed ID: 31392577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-the-Counter Tamsulosin for Men with Urinary Symptoms: A Simulated Self-Selection Study.
    Roehrborn CG; Lowe FC; Gittelman M; Wruck JM; Verbeek AE
    Urol Pract; 2020 Jan; 7(1):7-13. PubMed ID: 37317386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
    Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
    J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.
    Steele GS; Sullivan MP; Sleep DJ; Yalla SV
    J Urol; 2000 Aug; 164(2):344-8. PubMed ID: 10893581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
    Barqawi AB; Myers JB; O'Donnell C; Crawford ED
    BJU Int; 2007 Oct; 100(4):853-7. PubMed ID: 17662074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of moderate to severe lower urinary tract symptoms with incident type 2 diabetes and heart disease.
    Kupelian V; Araujo AB; Wittert GA; McKinlay JB
    J Urol; 2015 Feb; 193(2):581-6. PubMed ID: 25171906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Clinically Meaningful Changes in Lower Urinary Tract Symptoms Using the American Urological Association Symptom Index.
    Fuller TW; Ristau BT; Tepe SM; Benoit RM
    Urology; 2018 May; 115():139-143. PubMed ID: 29410322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.
    Martin S; Lange K; Haren MT; Taylor AW; Wittert G;
    J Urol; 2014 Jan; 191(1):130-7. PubMed ID: 23770136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional and longitudinal associations of sexual function with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Fwu CW; Kirkali Z; McVary KT; Burrows PK; Eggers PW; Kusek JW
    J Urol; 2015 Jan; 193(1):231-8. PubMed ID: 25150638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
    Ito H; Sano F; Ogawa T; Yao M
    Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1 -blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms.
    Lee YC; Juan YS; Liu CC; Bao BY; Wang CJ; Wu WJ; Huang CN; Huang SP
    BJU Int; 2016 Aug; 118(2):313-9. PubMed ID: 26940040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
    Dray E; Cameron AP; Clemens JQ; Qin Y; Covalschi D; Stoffel J
    J Urol; 2018 Oct; 200(4):868-874. PubMed ID: 29702098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.